Survivors of acute myocardial infarction (MI) face a significantly higher risk of experiencing new cardiovascular events, including cardiovascular death, compared to the general population. Scientific evidence indicates that this risk is particularly elevated during the first year following the initial event. In response to this challenge, a novel initiative spearheaded by the Heart Disease Department of the Bellvitge University Hospital (HUB), in collaboration with Novartis in a public-private partnership, has developed a pioneering tool in the intelligent use of data that could revolutionize prevention in the twelve months following a heart attack.

The Artemis project, through its digital control panel, provides real-time insights into the status of post-MI patients, identifying those at higher risk and proactively addressing potential complications with more effective preventive interventions. This project, the first of its kind nationally and unprecedented in Catalonia, combines process reengineering with Lean management methodology and the use of intelligent data for medical decision-making.

«We are beginning to monitor real-time macro health outcomes, enabling us to detect and locate patients outside the cardiovascular risk factor control range,» states Dr. Oona Meroño, cardiologist, director of the Preventive and Community Cardiology Program (post-MI), and co-coordinator of the Cardiac Rehabilitation Unit at HUB.

«Previously, unless the patient proactively contacted their cardiology team, we were unaware of health incidences beyond follow-up visits. Now, we can assess various parameters from analytics, biometric data, and other medical tests that may influence the patient’s progression,» Dr. Meroño elaborates. «This allows us to intervene timely, provide specific and individualized education, and enhance long-term outcomes,» she emphasizes.

Artemis, set to debut at the Catalan Society of Cardiology Congress on May 30th, operates as a multidisciplinary, patient-centered program catering to over 250 individuals annually.

Offering coordinated follow-up throughout the twelve months post-hospital discharge, spanning both hospital and primary care settings, the initiative orchestrates all necessary components for post-acute coronary syndrome rehabilitation and recovery.

The development of this control panel was made possible through the collaborative efforts of clinicians and engineers specialized in intelligent data usage. Artemis stands as a beacon of hope, leveraging technology and collaboration to safeguard the vulnerable period after a heart attack, ultimately improving the prognosis and quality of life for countless individuals navigating the aftermath of this life-altering event.

Article written by Hospital de Bellvitge



Hospital de Belllvitge